SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-007278
Filing Date
2008-11-14
Accepted
2008-11-14 12:44:00
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 RXI PHARMACEUTICALS CORPORATION b72454rpe10vq.htm 10-Q 162966
2 EX-10.1 WARRANT NO. A-1 DATED AUGUST 7, 2008 IN FAVOR OF J.P. TURNER PARTNERS, L b72454rpexv10w1.htm EX-10.1 95320
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b72454rpexv31w1.htm EX-31.1 8158
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b72454rpexv31w2.htm EX-31.2 8433
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b72454rpexv32w1.htm EX-32.1 4792
  Complete submission text file 0000950135-08-007278.txt   281000
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 081188846
SIC: 2834 Pharmaceutical Preparations